Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Osteoarthritis Analgesics Market Insights, Forecast to 2030

Global Osteoarthritis Analgesics Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-28

Pages: 128 Pages

Report ld: 3122329

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for osteoarthritis are mainly divided into two categories: over-the-counter drugs and prescription drugs. There are three main types: injection, oral and topical.

The global Osteoarthritis Analgesics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Osteoarthritis Analgesics include Pfizer, Bayer, Johnson & Johnson, Sanofi, Abbott, GlaxoSmithKline, TEVA, Almatica Pharma and Astellas Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Osteoarthritis Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Osteoarthritis Analgesics, also provides the sales of main regions and countries. of the upcoming market potential for Osteoarthritis Analgesics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Osteoarthritis Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Osteoarthritis Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Osteoarthritis Analgesics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Bayer, Johnson & Johnson, Sanofi, Abbott, GlaxoSmithKline, TEVA, Almatica Pharma and Astellas Pharma, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Osteoarthritis Analgesics Market Insights, Forecast to 2030
Global Osteoarthritis Analgesics Companies Covered
Pfizer, Bayer, Johnson & Johnson, Sanofi, Abbott, GlaxoSmithKline, TEVA, Almatica Pharma, Astellas Pharma, Iroko Pharmaceuticals, SK Chemicals, Eli Lilly, Crystal Genomics, Synartro, Mikasa Seiyaku, Daiichi Sankyo, Taisho Pharmaceutical, Sino Biopharmaceutical, Seikagaku, Novartis, Horizon Pharma, Mylan, Abiogen Pharma, Shanghai Haohai Biological Technology, Zhejiang ChengYi Pharmaceutical, Jiangsu Hengrui Medicine, Hunan Jingfeng Pharmaceutical, Beijing Tide Pharmaceutical, Jiangsu Simcere Pharmaceutical, Cspc Holdings, Concentric Analgesics
Global Osteoarthritis Analgesics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoarthritis Analgesics Market, Segment by Type
Injections

Oral Medications

Topical Medications
Global Osteoarthritis Analgesics Market, Segment by Application
Hospital

Personal

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Osteoarthritis Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Osteoarthritis Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Analgesics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

 1 Study Coverage
    1.1 Osteoarthritis Analgesics Product Introduction
    1.2 Market by Type
        1.2.1 Global Osteoarthritis Analgesics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Injections
        1.2.3 Oral Medications
        1.2.4 Topical Medications
    1.3 Market by Application
        1.3.1 Global Osteoarthritis Analgesics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Hospital
        1.3.3 Personal
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Osteoarthritis Analgesics Sales Estimates and Forecasts 2019-2030
    2.2 Global Osteoarthritis Analgesics Revenue by Region
        2.2.1 Global Osteoarthritis Analgesics Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Osteoarthritis Analgesics Revenue by Region (2019-2024)
        2.2.3 Global Osteoarthritis Analgesics Revenue by Region (2025-2030)
        2.2.4 Global Osteoarthritis Analgesics Revenue Market Share by Region (2019-2030)
    2.3 Global Osteoarthritis Analgesics Sales Estimates and Forecasts 2019-2030
    2.4 Global Osteoarthritis Analgesics Sales by Region
        2.4.1 Global Osteoarthritis Analgesics Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Osteoarthritis Analgesics Sales by Region (2019-2024)
        2.4.3 Global Osteoarthritis Analgesics Sales by Region (2025-2030)
        2.4.4 Global Osteoarthritis Analgesics Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Osteoarthritis Analgesics Sales by Manufacturers
        3.1.1 Global Osteoarthritis Analgesics Sales by Manufacturers (2019-2024)
        3.1.2 Global Osteoarthritis Analgesics Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Analgesics in 2023
    3.2 Global Osteoarthritis Analgesics Revenue by Manufacturers
        3.2.1 Global Osteoarthritis Analgesics Revenue by Manufacturers (2019-2024)
        3.2.2 Global Osteoarthritis Analgesics Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Analgesics Revenue in 2023
    3.3 Global Key Players of Osteoarthritis Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
    3.4 Global Osteoarthritis Analgesics Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Osteoarthritis Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Osteoarthritis Analgesics, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Osteoarthritis Analgesics, Product Offered and Application
    3.8 Global Key Manufacturers of Osteoarthritis Analgesics, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Osteoarthritis Analgesics Sales by Type
        4.1.1 Global Osteoarthritis Analgesics Historical Sales by Type (2019-2024)
        4.1.2 Global Osteoarthritis Analgesics Forecasted Sales by Type (2025-2030)
        4.1.3 Global Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    4.2 Global Osteoarthritis Analgesics Revenue by Type
        4.2.1 Global Osteoarthritis Analgesics Historical Revenue by Type (2019-2024)
        4.2.2 Global Osteoarthritis Analgesics Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    4.3 Global Osteoarthritis Analgesics Price by Type
        4.3.1 Global Osteoarthritis Analgesics Price by Type (2019-2024)
        4.3.2 Global Osteoarthritis Analgesics Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Osteoarthritis Analgesics Sales by Application
        5.1.1 Global Osteoarthritis Analgesics Historical Sales by Application (2019-2024)
        5.1.2 Global Osteoarthritis Analgesics Forecasted Sales by Application (2025-2030)
        5.1.3 Global Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    5.2 Global Osteoarthritis Analgesics Revenue by Application
        5.2.1 Global Osteoarthritis Analgesics Historical Revenue by Application (2019-2024)
        5.2.2 Global Osteoarthritis Analgesics Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    5.3 Global Osteoarthritis Analgesics Price by Application
        5.3.1 Global Osteoarthritis Analgesics Price by Application (2019-2024)
        5.3.2 Global Osteoarthritis Analgesics Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Osteoarthritis Analgesics Market Size by Type
        6.1.1 US & Canada Osteoarthritis Analgesics Sales by Type (2019-2030)
        6.1.2 US & Canada Osteoarthritis Analgesics Revenue by Type (2019-2030)
    6.2 US & Canada Osteoarthritis Analgesics Market Size by Application
        6.2.1 US & Canada Osteoarthritis Analgesics Sales by Application (2019-2030)
        6.2.2 US & Canada Osteoarthritis Analgesics Revenue by Application (2019-2030)
    6.3 US & Canada Osteoarthritis Analgesics Market Size by Country
        6.3.1 US & Canada Osteoarthritis Analgesics Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Osteoarthritis Analgesics Sales by Country (2019-2030)
        6.3.3 US & Canada Osteoarthritis Analgesics Revenue by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Osteoarthritis Analgesics Market Size by Type
        7.1.1 Europe Osteoarthritis Analgesics Sales by Type (2019-2030)
        7.1.2 Europe Osteoarthritis Analgesics Revenue by Type (2019-2030)
    7.2 Europe Osteoarthritis Analgesics Market Size by Application
        7.2.1 Europe Osteoarthritis Analgesics Sales by Application (2019-2030)
        7.2.2 Europe Osteoarthritis Analgesics Revenue by Application (2019-2030)
    7.3 Europe Osteoarthritis Analgesics Market Size by Country
        7.3.1 Europe Osteoarthritis Analgesics Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Osteoarthritis Analgesics Sales by Country (2019-2030)
        7.3.3 Europe Osteoarthritis Analgesics Revenue by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Osteoarthritis Analgesics Market Size
        8.1.1 China Osteoarthritis Analgesics Sales  (2019-2030)
        8.1.2 China Osteoarthritis Analgesics Revenue  (2019-2030)
    8.2 China Osteoarthritis Analgesics Market Size by Application
        8.2.1 China Osteoarthritis Analgesics Sales by Application (2019-2030)
        8.2.2 China Osteoarthritis Analgesics Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Osteoarthritis Analgesics Market Size by Type
        9.1.1 Asia Osteoarthritis Analgesics Sales by Type (2019-2030)
        9.1.2 Asia Osteoarthritis Analgesics Revenue by Type (2019-2030)
    9.2 Asia Osteoarthritis Analgesics Market Size by Application
        9.2.1 Asia Osteoarthritis Analgesics Sales by Application (2019-2030)
        9.2.2 Asia Osteoarthritis Analgesics Revenue by Application (2019-2030)
    9.3 Asia Osteoarthritis Analgesics Sales by Region
        9.3.1 Asia Osteoarthritis Analgesics Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Osteoarthritis Analgesics Revenue by Region (2019-2030)
        9.3.3 Asia Osteoarthritis Analgesics Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Market Size by Type
        10.1.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Market Size by Application
        10.2.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country
        10.3.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Pfizer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Bayer
        11.2.1 Bayer Company Information
        11.2.2 Bayer Overview
        11.2.3 Bayer Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Bayer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Johnson & Johnson Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Company Information
        11.4.2 Sanofi Overview
        11.4.3 Sanofi Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Sanofi Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sanofi Recent Developments
    11.5 Abbott
        11.5.1 Abbott Company Information
        11.5.2 Abbott Overview
        11.5.3 Abbott Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Abbott Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Abbott Recent Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Information
        11.6.2 GlaxoSmithKline Overview
        11.6.3 GlaxoSmithKline Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 GlaxoSmithKline Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 GlaxoSmithKline Recent Developments
    11.7 TEVA
        11.7.1 TEVA Company Information
        11.7.2 TEVA Overview
        11.7.3 TEVA Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 TEVA Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 TEVA Recent Developments
    11.8 Almatica Pharma
        11.8.1 Almatica Pharma Company Information
        11.8.2 Almatica Pharma Overview
        11.8.3 Almatica Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Almatica Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Almatica Pharma Recent Developments
    11.9 Astellas Pharma
        11.9.1 Astellas Pharma Company Information
        11.9.2 Astellas Pharma Overview
        11.9.3 Astellas Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Astellas Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Astellas Pharma Recent Developments
    11.10 Iroko Pharmaceuticals
        11.10.1 Iroko Pharmaceuticals Company Information
        11.10.2 Iroko Pharmaceuticals Overview
        11.10.3 Iroko Pharmaceuticals Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 Iroko Pharmaceuticals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Iroko Pharmaceuticals Recent Developments
    11.11 SK Chemicals
        11.11.1 SK Chemicals Company Information
        11.11.2 SK Chemicals Overview
        11.11.3 SK Chemicals Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 SK Chemicals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 SK Chemicals Recent Developments
    11.12 Eli Lilly
        11.12.1 Eli Lilly Company Information
        11.12.2 Eli Lilly Overview
        11.12.3 Eli Lilly Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Eli Lilly Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Eli Lilly Recent Developments
    11.13 Crystal Genomics
        11.13.1 Crystal Genomics Company Information
        11.13.2 Crystal Genomics Overview
        11.13.3 Crystal Genomics Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Crystal Genomics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Crystal Genomics Recent Developments
    11.14 Synartro
        11.14.1 Synartro Company Information
        11.14.2 Synartro Overview
        11.14.3 Synartro Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.14.4 Synartro Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Synartro Recent Developments
    11.15 Mikasa Seiyaku
        11.15.1 Mikasa Seiyaku Company Information
        11.15.2 Mikasa Seiyaku Overview
        11.15.3 Mikasa Seiyaku Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.15.4 Mikasa Seiyaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Mikasa Seiyaku Recent Developments
    11.16 Daiichi Sankyo
        11.16.1 Daiichi Sankyo Company Information
        11.16.2 Daiichi Sankyo Overview
        11.16.3 Daiichi Sankyo Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.16.4 Daiichi Sankyo Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Daiichi Sankyo Recent Developments
    11.17 Taisho Pharmaceutical
        11.17.1 Taisho Pharmaceutical Company Information
        11.17.2 Taisho Pharmaceutical Overview
        11.17.3 Taisho Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.17.4 Taisho Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Taisho Pharmaceutical Recent Developments
    11.18 Sino Biopharmaceutical
        11.18.1 Sino Biopharmaceutical Company Information
        11.18.2 Sino Biopharmaceutical Overview
        11.18.3 Sino Biopharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.18.4 Sino Biopharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Sino Biopharmaceutical Recent Developments
    11.19 Seikagaku
        11.19.1 Seikagaku Company Information
        11.19.2 Seikagaku Overview
        11.19.3 Seikagaku Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.19.4 Seikagaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Seikagaku Recent Developments
    11.20 Novartis
        11.20.1 Novartis Company Information
        11.20.2 Novartis Overview
        11.20.3 Novartis Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.20.4 Novartis Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Novartis Recent Developments
    11.21 Horizon Pharma
        11.21.1 Horizon Pharma Company Information
        11.21.2 Horizon Pharma Overview
        11.21.3 Horizon Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.21.4 Horizon Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.21.5 Horizon Pharma Recent Developments
    11.22 Mylan
        11.22.1 Mylan Company Information
        11.22.2 Mylan Overview
        11.22.3 Mylan Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.22.4 Mylan Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.22.5 Mylan Recent Developments
    11.23 Abiogen Pharma
        11.23.1 Abiogen Pharma Company Information
        11.23.2 Abiogen Pharma Overview
        11.23.3 Abiogen Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.23.4 Abiogen Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.23.5 Abiogen Pharma Recent Developments
    11.24 Shanghai Haohai Biological Technology
        11.24.1 Shanghai Haohai Biological Technology Company Information
        11.24.2 Shanghai Haohai Biological Technology Overview
        11.24.3 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.24.4 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.24.5 Shanghai Haohai Biological Technology Recent Developments
    11.25 Zhejiang ChengYi Pharmaceutical
        11.25.1 Zhejiang ChengYi Pharmaceutical Company Information
        11.25.2 Zhejiang ChengYi Pharmaceutical Overview
        11.25.3 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.25.4 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.25.5 Zhejiang ChengYi Pharmaceutical Recent Developments
    11.26 Jiangsu Hengrui Medicine
        11.26.1 Jiangsu Hengrui Medicine Company Information
        11.26.2 Jiangsu Hengrui Medicine Overview
        11.26.3 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.26.4 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.26.5 Jiangsu Hengrui Medicine Recent Developments
    11.27 Hunan Jingfeng Pharmaceutical
        11.27.1 Hunan Jingfeng Pharmaceutical Company Information
        11.27.2 Hunan Jingfeng Pharmaceutical Overview
        11.27.3 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.27.4 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.27.5 Hunan Jingfeng Pharmaceutical Recent Developments
    11.28 Beijing Tide Pharmaceutical
        11.28.1 Beijing Tide Pharmaceutical Company Information
        11.28.2 Beijing Tide Pharmaceutical Overview
        11.28.3 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.28.4 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.28.5 Beijing Tide Pharmaceutical Recent Developments
    11.29 Jiangsu Simcere Pharmaceutical
        11.29.1 Jiangsu Simcere Pharmaceutical Company Information
        11.29.2 Jiangsu Simcere Pharmaceutical Overview
        11.29.3 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.29.4 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
    11.30 Cspc Holdings
        11.30.1 Cspc Holdings Company Information
        11.30.2 Cspc Holdings Overview
        11.30.3 Cspc Holdings Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.30.4 Cspc Holdings Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.30.5 Cspc Holdings Recent Developments
    11.31 Concentric Analgesics
        11.31.1 Concentric Analgesics Company Information
        11.31.2 Concentric Analgesics Overview
        11.31.3 Concentric Analgesics Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2019-2024)
        11.31.4 Concentric Analgesics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
        11.31.5 Concentric Analgesics Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Osteoarthritis Analgesics Industry Chain Analysis
    12.2 Osteoarthritis Analgesics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Osteoarthritis Analgesics Production Mode & Process
    12.4 Osteoarthritis Analgesics Sales and Marketing
        12.4.1 Osteoarthritis Analgesics Sales Channels
        12.4.2 Osteoarthritis Analgesics Distributors
    12.5 Osteoarthritis Analgesics Customers

 13 Market Dynamics
    13.1 Osteoarthritis Analgesics Industry Trends
    13.2 Osteoarthritis Analgesics Market Drivers
    13.3 Osteoarthritis Analgesics Market Challenges
    13.4 Osteoarthritis Analgesics Market Restraints

 14 Key Findings in The Global Osteoarthritis Analgesics Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Osteoarthritis Analgesics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Injections
    Table 3. Major Manufacturers of Oral Medications
    Table 4. Major Manufacturers of Topical Medications
    Table 5. Global Osteoarthritis Analgesics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Osteoarthritis Analgesics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Osteoarthritis Analgesics Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Osteoarthritis Analgesics Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Osteoarthritis Analgesics Revenue Market Share by Region (2019-2024)
    Table 10. Global Osteoarthritis Analgesics Revenue Market Share by Region (2025-2030)
    Table 11. Global Osteoarthritis Analgesics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Osteoarthritis Analgesics Sales by Region (2019-2024) & (K Units)
    Table 13. Global Osteoarthritis Analgesics Sales by Region (2025-2030) & (K Units)
    Table 14. Global Osteoarthritis Analgesics Sales Market Share by Region (2019-2024)
    Table 15. Global Osteoarthritis Analgesics Sales Market Share by Region (2025-2030)
    Table 16. Global Osteoarthritis Analgesics Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Osteoarthritis Analgesics Sales Share by Manufacturers (2019-2024)
    Table 18. Global Osteoarthritis Analgesics Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Osteoarthritis Analgesics Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Osteoarthritis Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Osteoarthritis Analgesics Price by Manufacturers 2019-2024 (US$/Unit)
    Table 22. Global Osteoarthritis Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Osteoarthritis Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Analgesics as of 2023)
    Table 24. Global Key Manufacturers of Osteoarthritis Analgesics, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Osteoarthritis Analgesics, Product Offered and Application
    Table 26. Global Key Manufacturers of Osteoarthritis Analgesics, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 29. Global Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 30. Global Osteoarthritis Analgesics Sales Share by Type (2019-2024)
    Table 31. Global Osteoarthritis Analgesics Sales Share by Type (2025-2030)
    Table 32. Global Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Osteoarthritis Analgesics Revenue Share by Type (2019-2024)
    Table 35. Global Osteoarthritis Analgesics Revenue Share by Type (2025-2030)
    Table 36. Osteoarthritis Analgesics Price by Type (2019-2024) & (US$/Unit)
    Table 37. Global Osteoarthritis Analgesics Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 38. Global Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 39. Global Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 40. Global Osteoarthritis Analgesics Sales Share by Application (2019-2024)
    Table 41. Global Osteoarthritis Analgesics Sales Share by Application (2025-2030)
    Table 42. Global Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Osteoarthritis Analgesics Revenue Share by Application (2019-2024)
    Table 45. Global Osteoarthritis Analgesics Revenue Share by Application (2025-2030)
    Table 46. Osteoarthritis Analgesics Price by Application (2019-2024) & (US$/Unit)
    Table 47. Global Osteoarthritis Analgesics Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 48. US & Canada Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Osteoarthritis Analgesics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Osteoarthritis Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Osteoarthritis Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Osteoarthritis Analgesics Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Osteoarthritis Analgesics Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Osteoarthritis Analgesics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Osteoarthritis Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Osteoarthritis Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Osteoarthritis Analgesics Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Osteoarthritis Analgesics Sales by Country (2025-2030) & (K Units)
    Table 74. China Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 75. China Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 76. China Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 79. China Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 80. China Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Osteoarthritis Analgesics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Osteoarthritis Analgesics Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Osteoarthritis Analgesics Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Osteoarthritis Analgesics Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Osteoarthritis Analgesics Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country (2025-2030) & (K Units)
    Table 108. Pfizer Company Information
    Table 109. Pfizer Description and Major Businesses
    Table 110. Pfizer Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. Pfizer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Pfizer Recent Developments
    Table 113. Bayer Company Information
    Table 114. Bayer Description and Major Businesses
    Table 115. Bayer Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. Bayer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bayer Recent Developments
    Table 118. Johnson & Johnson Company Information
    Table 119. Johnson & Johnson Description and Major Businesses
    Table 120. Johnson & Johnson Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. Johnson & Johnson Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Johnson & Johnson Recent Developments
    Table 123. Sanofi Company Information
    Table 124. Sanofi Description and Major Businesses
    Table 125. Sanofi Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Sanofi Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Sanofi Recent Developments
    Table 128. Abbott Company Information
    Table 129. Abbott Description and Major Businesses
    Table 130. Abbott Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 131. Abbott Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Abbott Recent Developments
    Table 133. GlaxoSmithKline Company Information
    Table 134. GlaxoSmithKline Description and Major Businesses
    Table 135. GlaxoSmithKline Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 136. GlaxoSmithKline Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. GlaxoSmithKline Recent Developments
    Table 138. TEVA Company Information
    Table 139. TEVA Description and Major Businesses
    Table 140. TEVA Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 141. TEVA Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. TEVA Recent Developments
    Table 143. Almatica Pharma Company Information
    Table 144. Almatica Pharma Description and Major Businesses
    Table 145. Almatica Pharma Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 146. Almatica Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Almatica Pharma Recent Developments
    Table 148. Astellas Pharma Company Information
    Table 149. Astellas Pharma Description and Major Businesses
    Table 150. Astellas Pharma Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 151. Astellas Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Astellas Pharma Recent Developments
    Table 153. Iroko Pharmaceuticals Company Information
    Table 154. Iroko Pharmaceuticals Description and Major Businesses
    Table 155. Iroko Pharmaceuticals Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 156. Iroko Pharmaceuticals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Iroko Pharmaceuticals Recent Developments
    Table 158. SK Chemicals Company Information
    Table 159. SK Chemicals Description and Major Businesses
    Table 160. SK Chemicals Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 161. SK Chemicals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. SK Chemicals Recent Developments
    Table 163. Eli Lilly Company Information
    Table 164. Eli Lilly Description and Major Businesses
    Table 165. Eli Lilly Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 166. Eli Lilly Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Eli Lilly Recent Developments
    Table 168. Crystal Genomics Company Information
    Table 169. Crystal Genomics Description and Major Businesses
    Table 170. Crystal Genomics Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 171. Crystal Genomics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Crystal Genomics Recent Developments
    Table 173. Synartro Company Information
    Table 174. Synartro Description and Major Businesses
    Table 175. Synartro Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 176. Synartro Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Synartro Recent Developments
    Table 178. Mikasa Seiyaku Company Information
    Table 179. Mikasa Seiyaku Description and Major Businesses
    Table 180. Mikasa Seiyaku Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 181. Mikasa Seiyaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Mikasa Seiyaku Recent Developments
    Table 183. Daiichi Sankyo Company Information
    Table 184. Daiichi Sankyo Description and Major Businesses
    Table 185. Daiichi Sankyo Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 186. Daiichi Sankyo Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Daiichi Sankyo Recent Developments
    Table 188. Taisho Pharmaceutical Company Information
    Table 189. Taisho Pharmaceutical Description and Major Businesses
    Table 190. Taisho Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 191. Taisho Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Taisho Pharmaceutical Recent Developments
    Table 193. Sino Biopharmaceutical Company Information
    Table 194. Sino Biopharmaceutical Description and Major Businesses
    Table 195. Sino Biopharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 196. Sino Biopharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Sino Biopharmaceutical Recent Developments
    Table 198. Seikagaku Company Information
    Table 199. Seikagaku Description and Major Businesses
    Table 200. Seikagaku Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 201. Seikagaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Seikagaku Recent Developments
    Table 203. Novartis Company Information
    Table 204. Novartis Description and Major Businesses
    Table 205. Novartis Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 206. Novartis Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Novartis Recent Developments
    Table 208. Horizon Pharma Company Information
    Table 209. Horizon Pharma Description and Major Businesses
    Table 210. Horizon Pharma Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 211. Horizon Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. Horizon Pharma Recent Developments
    Table 213. Mylan Company Information
    Table 214. Mylan Description and Major Businesses
    Table 215. Mylan Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 216. Mylan Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Mylan Recent Developments
    Table 218. Abiogen Pharma Company Information
    Table 219. Abiogen Pharma Description and Major Businesses
    Table 220. Abiogen Pharma Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 221. Abiogen Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 222. Abiogen Pharma Recent Developments
    Table 223. Shanghai Haohai Biological Technology Company Information
    Table 224. Shanghai Haohai Biological Technology Description and Major Businesses
    Table 225. Shanghai Haohai Biological Technology Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 226. Shanghai Haohai Biological Technology Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 227. Shanghai Haohai Biological Technology Recent Developments
    Table 228. Zhejiang ChengYi Pharmaceutical Company Information
    Table 229. Zhejiang ChengYi Pharmaceutical Description and Major Businesses
    Table 230. Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 231. Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 232. Zhejiang ChengYi Pharmaceutical Recent Developments
    Table 233. Jiangsu Hengrui Medicine Company Information
    Table 234. Jiangsu Hengrui Medicine Description and Major Businesses
    Table 235. Jiangsu Hengrui Medicine Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 236. Jiangsu Hengrui Medicine Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 237. Jiangsu Hengrui Medicine Recent Developments
    Table 238. Hunan Jingfeng Pharmaceutical Company Information
    Table 239. Hunan Jingfeng Pharmaceutical Description and Major Businesses
    Table 240. Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 241. Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 242. Hunan Jingfeng Pharmaceutical Recent Developments
    Table 243. Beijing Tide Pharmaceutical Company Information
    Table 244. Beijing Tide Pharmaceutical Description and Major Businesses
    Table 245. Beijing Tide Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 246. Beijing Tide Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 247. Beijing Tide Pharmaceutical Recent Developments
    Table 248. Jiangsu Simcere Pharmaceutical Company Information
    Table 249. Jiangsu Simcere Pharmaceutical Description and Major Businesses
    Table 250. Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 251. Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 252. Jiangsu Simcere Pharmaceutical Recent Developments
    Table 253. Cspc Holdings Company Information
    Table 254. Cspc Holdings Description and Major Businesses
    Table 255. Cspc Holdings Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 256. Cspc Holdings Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 257. Cspc Holdings Recent Developments
    Table 258. Concentric Analgesics Company Information
    Table 259. Concentric Analgesics Description and Major Businesses
    Table 260. Concentric Analgesics Osteoarthritis Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 261. Concentric Analgesics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 262. Concentric Analgesics Recent Developments
    Table 263. Key Raw Materials Lists
    Table 264. Raw Materials Key Suppliers Lists
    Table 265. Osteoarthritis Analgesics Distributors List
    Table 266. Osteoarthritis Analgesics Customers List
    Table 267. Osteoarthritis Analgesics Market Trends
    Table 268. Osteoarthritis Analgesics Market Drivers
    Table 269. Osteoarthritis Analgesics Market Challenges
    Table 270. Osteoarthritis Analgesics Market Restraints
    Table 271. Research Programs/Design for This Report
    Table 272. Key Data Information from Secondary Sources
    Table 273. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osteoarthritis Analgesics Product Picture
    Figure 2. Global Osteoarthritis Analgesics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Osteoarthritis Analgesics Market Share by Type in 2023 & 2030
    Figure 4. Injections Product Picture
    Figure 5. Oral Medications Product Picture
    Figure 6. Topical Medications Product Picture
    Figure 7. Global Osteoarthritis Analgesics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Osteoarthritis Analgesics Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Personal
    Figure 11. Others
    Figure 12. Osteoarthritis Analgesics Report Years Considered
    Figure 13. Global Osteoarthritis Analgesics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Osteoarthritis Analgesics Revenue 2019-2030 (US$ Million)
    Figure 15. Global Osteoarthritis Analgesics Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Osteoarthritis Analgesics Revenue Market Share by Region (2019-2030)
    Figure 17. Global Osteoarthritis Analgesics Sales 2019-2030 ((K Units)
    Figure 18. Global Osteoarthritis Analgesics Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Osteoarthritis Analgesics Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Osteoarthritis Analgesics Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Osteoarthritis Analgesics Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Osteoarthritis Analgesics Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Osteoarthritis Analgesics Sales YoY (2019-2030) & (K Units)
    Figure 24. China Osteoarthritis Analgesics Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Osteoarthritis Analgesics Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Osteoarthritis Analgesics Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Osteoarthritis Analgesics Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Osteoarthritis Analgesics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Analgesics in the World: Market Share by Osteoarthritis Analgesics Revenue in 2023
    Figure 31. Global Osteoarthritis Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    Figure 33. Global Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    Figure 34. Global Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    Figure 35. Global Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Osteoarthritis Analgesics Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Osteoarthritis Analgesics Sales Share by Country (2019-2030)
    Figure 42. U.S. Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    Figure 45. Europe Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    Figure 47. Europe Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Osteoarthritis Analgesics Revenue Share by Country (2019-2030)
    Figure 49. Europe Osteoarthritis Analgesics Sales Share by Country (2019-2030)
    Figure 50. Germany Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 51. France Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 55. China Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    Figure 56. China Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    Figure 57. China Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    Figure 58. China Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Osteoarthritis Analgesics Sales Market Share by Type (2019-2030)
    Figure 60. Asia Osteoarthritis Analgesics Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Osteoarthritis Analgesics Sales Market Share by Application (2019-2030)
    Figure 62. Asia Osteoarthritis Analgesics Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Osteoarthritis Analgesics Revenue Share by Region (2019-2030)
    Figure 64. Asia Osteoarthritis Analgesics Sales Share by Region (2019-2030)
    Figure 65. Japan Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Osteoarthritis Analgesics Revenue (2019-2030) & (US$ Million)
    Figure 69. India

Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for osteoarthritis are mainly divided into two categories: over-the-counter drugs and prescription drugs. There are three main types: injection, oral and topical.

The global Osteoarthritis Analgesics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Osteoarthritis Analgesics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Descriptive company profiles of the major global players, including Pfizer, Bayer, Johnson & Johnson, Sanofi, Abbott, GlaxoSmithKline, TEVA, Almatica Pharma and Astellas Pharma, etc.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-04-28

Pages: 128 Pages

Report ld: 3122329

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4900.00

Multi Users License

USD 7350.00

Corporate Users License

USD 9800.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?